Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
- Latest News
- Most Popular
- What is the Stock Market's Achilles Heel?
- RTI: Prediction Contest: S&P 500 on Dec. 31st
- Biotechnology ETF Investing 101
- 3 Dividend Stocks at Reasonable Prices
- RTI: Are You Doing the Elon Musk Trade?
- Buy These ETFs to Profit from "Sector Rotation"
- Oil & Gas Industry Stock Outlook - May 2013
- Uncharted Territory
- Options Strategies & the Zacks Rank
- AWS 5/20: The Fed In Focus This Week
- PFP 5/20: Will We Touch 1700?
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/20/2013
| Company Name | Symbol | %Change |
|---|---|---|
| NOAH HOLDING | NOAH | 11.73% |
| ORBOTECH LTD | ORBK | 11.41% |
| VIPSHOP HOLD | VIPS | 8.66% |
| RENEWABLE EN | REGI | 8.08% |
| EAGLE BULK S | EGLE | 7.61% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
This Zacks #1 Rank (Strong Buy) has double-digit growth, increasing estimates and attractive valuations.
Company Description
Transcend Services provides clinical documentation services for healthcare organizations, included transcription, data extraction and reporting tools.
Better Than Expected Quarter
Transcend Services announced fourth-quarter and year-end results on Feb 3 which turned out to be better than expected. Earnings per share for the quarter came out to 27 cents, beating the Zacks Consensus Estimate by a penny.
Revenue for the quarter was up 26% to nearly $27 million. Much of that increase was due to the acquisition of Heartland, but organic revenue growth was still an impressive 9%. Transcend Services was expecting the October acquisition to weigh on margins in the short term, however they actually were able to expand those margins.
Bullish Outlook
Analysts quickly raised estimates for full-year 2011 and 2012 on the news. The Zacks Consensus Estimate for this year is up 7 cents, to $1.20. Next year's forecast also rose 7 cents on average, to $1.37.
If Transcend Services meets these targets, the annual growth rates will be 38% and 14%, respectively.
Valuations
Shares of TRCR are trading with some attractive valuations, in addition to those double-digit growth rates. The PEG ratio is coming in a shade under 1.0, which means that the growth rates are priced at a slight discount.
The forward P/E is about 17 times, which won't necessarily woo tradition value investors, but is in line with the peer group. TRCR has a price to sales ratio near 2.2, better than the industry mean.
The Chart
TRCR has developed a nice level of support over the recent months, limiting some of the downside risk. Now, with the rising estimates on the recent quarterly report, there is a good case for shares to move even higher.
Bill Wilton is the Aggressive Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the market-beating Zacks Small Cap Trader service